The CARPEM receives the SIRIC label for the 3rd time

We are proud to announce the renewal of the SIRIC CARPEM for the period 2023-2027. Our application is one of the 8 recipients of the SIRIC 2022 call for applications launched by the INCa. This success demonstrates the excellence of our teams’ collaborative work.

The new CARPEM project entitled “CARPEM3: Cancer Research in multiple dimensions to accelerate Precision Medicine” is based on 3 integrated research programs:
1. “Multiscaling approaches to identify predictors of cancer patient outcomes”
2. “Implementation of markers in the clinic – from single to composite biomarker”.
3. “Implementing a patient and relatives engagement program to promote patient empowerment in translational research

This project brings together the strengths of 22 research teams and 12 clinical teams of the Institut du Cancer Paris CARPEM. Beyond their recognized expertise in basic and clinical research, our teams have a real know-how in translational research.
Four institutions are partners in this project: AP-HP, Université Paris Cité, Université Sorbonne Paris Nord and INSERM.

More details on the CARPEM project will be available soon on our website.